Metraipolis › archive › dc_f236bb75de21

Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies — Europe PMC PMID:42797439

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42797439
DOI
10.3390/ph19091393
License (as archived)
solo-consultazione
Archived
2026-10-16T06:21:07.317Z
SHA-256 of the archived text
aacb9fe0e4b5fd32e0374607ec286b9a7a1af2f687fd3669dfdcec8c21ecca58
Stable URL of this page
https://metraipolis.com/documento/dc_f236bb75de21

How to cite

Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies — Europe PMC PMID:42797439 — Europe PMC (en), https://europepmc.org/article/MED/42797439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f236bb75de21 (Metraipolis archive dc_f236bb75de21, sha256 aacb9fe0e4b5fd32e0374607ec286b9a7a1af2f687fd3669dfdcec8c21ecca58)
BibTeX
@misc{dcf236bb75de21,
  title = {Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies — Europe PMC PMID:42797439},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797439},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f236bb75de21; sha256 aacb9fe0e4b5fd32e0374607ec286b9a7a1af2f687fd3669dfdcec8c21ecca58},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797439. Agents can read the archived copy with the MCP tool read_document.